Skip to content

CE mark study of a home self-test system for blood cell count and ear temperature

Protocol for the commercial study to enable CE marking for the sale of a whole white blood cell count, granulocyte blood cell count, and haemoglobin-measuring device and ear thermometer with telehub, within the European Union

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN71085103
Enrollment
150
Registered
2013-12-12
Start date
2014-02-17
Completion date
Unknown
Last updated
2017-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

This is CE mark trial to prove device suitability for intended use - no drug therapy, no patient specific state monitoring sought Not Applicable

Interventions

The purpose of the study is to provide evidence that after training patients are able to perform a finger prick and add a blood droplet to a cartridge for successful and accurate measurement of white

Sponsors

Philips Healthcare Incubator (Home Clinical Monitoring) (Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients attending clinics within St Thomas' Hospital, London, UK 2. Aged 18 - 85

Exclusion criteria

Exclusion criteria: Leukaemic patients

Design outcomes

Primary

MeasureTime frame
To prove the device can be CE marked for its intended use

Secondary

MeasureTime frame
No secondary outcome measures

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026